A recent study revealed that TGF-β signaling is involved in the development of nonalcoholic steatohepatitis-associated macrophages (NAMs), which express molecular markers, including TREM2, in the liver [24]. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatohepatitis.